Mini Review
Accepted on 09 Feb 2026
An updated review of the economic burden of Multiple Sclerosis: Direct and indirect costs
in Multiple Sclerosis and Neuroimmunology
Mini Review
Accepted on 09 Feb 2026
in Multiple Sclerosis and Neuroimmunology
Case Report
Accepted on 09 Feb 2026
in Hematology
Original Research
Accepted on 09 Feb 2026
in Experimental Endocrinology
Original Research
Accepted on 09 Feb 2026
in Public Mental Health
Original Research
Accepted on 09 Feb 2026
in Virology
Original Research
Accepted on 09 Feb 2026
in Marine Affairs and Policy
Review
Accepted on 09 Feb 2026
in Pediatric Cardiology
Original Research
Accepted on 09 Feb 2026
in Virtual Reality and Human Behaviour
Original Research
Accepted on 09 Feb 2026
in Computational Medicine
Original Research
Accepted on 09 Feb 2026
in Forest Management
Original Research
Accepted on 09 Feb 2026
in Inflammation
Policy Brief
Accepted on 09 Feb 2026
in Gender, Sex and Sexualities
Original Research
Accepted on 09 Feb 2026
in Cardio-Oncology
Correction
Accepted on 09 Feb 2026
in Respiratory Physiology and Pathophysiology
Mini Review
Accepted on 09 Feb 2026
in Inflammation
Opinion
Accepted on 09 Feb 2026
in Human Factors and Digital Health